中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
23期
123-124
,共2页
沙利度胺%化疗%急性白血病%治疗效果
沙利度胺%化療%急性白血病%治療效果
사리도알%화료%급성백혈병%치료효과
Thalidomide%Chemotherapy%Impatient leukemia%Cure effect
目的：探讨沙利度胺联合化疗在急性白血病患者中的临床治疗效果。方法随机选取2013年4月—2014年4月该院收治的60例急性白血病患者资料进行分析，根据不同治疗方案将患者分为对照组和实验组，对照组采用化疗治疗，实验组联合沙利度胺治疗，比较两组疗效。结果两组治疗前血浆VEGF、bFGF和骨髓MVD等指标差异不显著(P>0.05)；实验组治疗后血浆VEGF指标，骨髓MVD指标，显著低于对照组(P<0.05)；实验组治疗后bFGF指标为，显著高于对照组(P<0.05)。结论急性白血病患者采用沙利度胺联合化疗治疗效果理想，值得推广使用。
目的：探討沙利度胺聯閤化療在急性白血病患者中的臨床治療效果。方法隨機選取2013年4月—2014年4月該院收治的60例急性白血病患者資料進行分析，根據不同治療方案將患者分為對照組和實驗組，對照組採用化療治療，實驗組聯閤沙利度胺治療，比較兩組療效。結果兩組治療前血漿VEGF、bFGF和骨髓MVD等指標差異不顯著(P>0.05)；實驗組治療後血漿VEGF指標，骨髓MVD指標，顯著低于對照組(P<0.05)；實驗組治療後bFGF指標為，顯著高于對照組(P<0.05)。結論急性白血病患者採用沙利度胺聯閤化療治療效果理想，值得推廣使用。
목적：탐토사리도알연합화료재급성백혈병환자중적림상치료효과。방법수궤선취2013년4월—2014년4월해원수치적60례급성백혈병환자자료진행분석，근거불동치료방안장환자분위대조조화실험조，대조조채용화료치료，실험조연합사리도알치료，비교량조료효。결과량조치료전혈장VEGF、bFGF화골수MVD등지표차이불현저(P>0.05)；실험조치료후혈장VEGF지표，골수MVD지표，현저저우대조조(P<0.05)；실험조치료후bFGF지표위，현저고우대조조(P<0.05)。결론급성백혈병환자채용사리도알연합화료치료효과이상，치득추엄사용。
Objective The study sand benefit degree the An unite a chemotherapy in the clinical treatment effect in the impatient leukemia sufferer. Methods The data of 60 patients with acute leukemia treated in our hospital from April 2013 to April 2014 were analyzed, the patients were divided into control group and experimental group according to different treatment plan ,and the control group received chemotherapy treatment, the experimental group thalidomide treatment, two groups were compared. Results Before treatment, two groups of plasma VEGF, bFGF and bone marrow MVD and other indicators were not significantly different (P>0.05). After experiment set cures the blood plasma VEGF index sign,the marrow MVD index sign,show Zhao is lower than a matched control (P<0.05).Experiment set is after curing the bFGF index sign,show Zhao is higher than a matched control(P<0.05). Conclusion The ideal treatment effect of thalidomide combined with chemotherapy in acute leukemia patients, which is worthy to be popularized.
